Frag 176-191 stands as a groundbreaking advancement in the realm of fat metabolism. Derived from a modified amino acid sequence of growth hormone, Frag 176-191 has garnered significant attention for its lipolytic activity, as evidenced by numerous published studies. This compound operates directly on adipose fat tissues, fostering increased lipolysis and decreased lipogenesis.